Published • loading... • Updated
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit ...
The firm alleges Power Solutions misled investors regarding demand capture and manufacturing costs, prompting a reminder for potential lead plaintiffs.
- On May 4, 2026, Rosen Law Firm filed a class action lawsuit against Nektar Therapeutics, alleging that enrollment in the REZOLVE-AA trial violated protocol standards and misled investors regarding trial integrity.
- According to the complaint, Nektar failed to follow applicable enrollment instructions for the trial, which potentially skewed results and caused investors to purchase stock at artificially inflated prices during the class period.
- The class period for Nektar purchasers runs from February 26, 2025, through December 15, 2025, with the deadline for investors to move the Court for lead plaintiff status set for May 5, 2026.
- With a history of recovering over $438 million for investors in previous securities litigation, Rosen Law is pursuing damages for shareholders who suffered losses due to the alleged misleading statements.
- Eligible investors may seek compensation through this class action, though they must determine whether to seek lead plaintiff status or remain as absent class members who do not actively direct the litigation.
Insights by Ground AI
34 Articles
34 Articles
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the ...
LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (NASDAQ: GOSS ) for violations of §§10(b)…
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit ...
LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA ) violations of §§10(b) and…
·Nebraska, United States
Read Full Article
Coverage Details
Total News Sources34
Leaning Left9Leaning Right4Center15Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 32%
C 54%
14%
Factuality
To view factuality data please Upgrade to Premium
